EC

EcoR1 Capital Portfolio holdings

AUM $2.08B
1-Year Est. Return 69.18%
This Quarter Est. Return
1 Year Est. Return
+69.18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.08B
AUM Growth
+$396M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
42
New
Increased
Reduced
Closed

Top Buys

1 +$61.3M
2 +$32.7M
3 +$21.8M
4
MBX
MBX Biosciences
MBX
+$17M
5
AQST icon
Aquestive Therapeutics
AQST
+$14.7M

Top Sells

1 +$191M
2 +$107M
3 +$34M
4
KURA icon
Kura Oncology
KURA
+$29.4M
5
AKRO icon
Akero Therapeutics
AKRO
+$23.5M

Sector Composition

1 Healthcare 99.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZYME icon
1
Zymeworks
ZYME
$2.01B
$392M 18.83%
22,970,388
ANAB icon
2
AnaptysBio
ANAB
$1.15B
$241M 11.58%
7,880,094
QURE icon
3
uniQure
QURE
$1.71B
$233M 11.17%
3,988,971
JAZZ icon
4
Jazz Pharmaceuticals
JAZZ
$10.7B
$225M 10.79%
1,706,469
CRNX icon
5
Crinetics Pharmaceuticals
CRNX
$4.32B
$179M 8.57%
4,288,120
CRSP icon
6
CRISPR Therapeutics
CRSP
$5.1B
$90M 4.32%
1,389,276
TNGX icon
7
Tango Therapeutics
TNGX
$1.47B
$89.3M 4.29%
10,630,736
ORIC icon
8
Oric Pharmaceuticals
ORIC
$1.16B
$80.7M 3.87%
6,728,116
+5,110,048
APLS icon
9
Apellis Pharmaceuticals
APLS
$2.69B
$78M 3.74%
3,447,156
-8,448,652
XNCR icon
10
Xencor
XNCR
$1.24B
$72.1M 3.46%
6,144,767
GLPG icon
11
Galapagos
GLPG
$2.06B
$57.7M 2.77%
1,667,119
+630,174
IMNM icon
12
Immunome
IMNM
$1.69B
$47.8M 2.29%
4,079,415
ETON icon
13
Eton Pharmaceutcials
ETON
$433M
$44.1M 2.12%
2,030,544
MBX
14
MBX Biosciences
MBX
$1.55B
$37.2M 1.78%
2,123,604
+973,810
MDGL icon
15
Madrigal Pharmaceuticals
MDGL
$13.6B
$34.4M 1.65%
75,000
RNA icon
16
Avidity Biosciences
RNA
$10.8B
$33.3M 1.6%
765,000
+265,000
BBOT
17
BridgeBio Oncology
BBOT
$985M
$32.7M 1.57%
+2,823,126
NGNE icon
18
Neurogene
NGNE
$327M
$22M 1.06%
1,271,342
ALKS icon
19
Alkermes
ALKS
$4.88B
$15M 0.72%
500,000
AQST icon
20
Aquestive Therapeutics
AQST
$755M
$14.7M 0.7%
+2,625,000
MTSR
21
DELISTED
Metsera Inc
MTSR
$14.2M 0.68%
271,529
CNTA
22
Centessa Pharmaceuticals
CNTA
$4.29B
$13.3M 0.64%
+550,000
PRME icon
23
Prime Medicine
PRME
$690M
$8.55M 0.41%
+1,543,326
ATRA icon
24
Atara Biotherapeutics
ATRA
$109M
$8.21M 0.39%
573,183
KURA icon
25
Kura Oncology
KURA
$1.06B
$7.72M 0.37%
872,500
-3,327,500